Drug intelligence / Profile preview

ibuprofen + diclofenac potassium

Development stage
Preclinical
Lead developer
Shanghai Children’s Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Ibuprofen + diclofenac potassium is a combination of two non-steroidal anti-inflammatory drugs (NSAIDs) utilized for the management of acute and postoperative pain. Ibuprofen, a propionic acid derivative, and diclofenac potassium, a phenylacetic acid derivative, both function by inhibiting the cyclooxygenase (COX) enzymes, COX-1 and COX-2. This inhibition prevents the conversion of arachidonic acid into prostaglandins, which are key mediators of pain, inflammation, and fever. The use of the potassium salt of diclofenac provides a faster onset of action compared to the sodium salt, making it particularly effective for acute pain scenarios. This specific combination has been investigated by Shanghai Children’s Hospital as part of a multimodal analgesia strategy for pediatric patients undergoing surgical correction for funnel chest (pectus excavatum), aiming to provide superior pain relief while potentially reducing the requirement for opioid analgesics.

Other names
ibuprofen and diclofenac potassium combination
02

Targets

ASIC (ASIC family)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PPARG (Peroxisome proliferator-activated receptor gamma)Kir (Inward-rectifier potassium channels)

Beyond the preview

Go deeper on ibuprofen + diclofenac potassium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + diclofenac potassium.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call